Laura M. Bohn, Ph.D.

2003-2008 The Ohio State University College of Medicine 
 2009- Molecular Therapeutics & Neuroscience Scripps Research Institute Florida 
Pharmacology, Neuropharmacology, Neuroscience
"Laura Bohn"
Mean distance: 15.86 (cluster 11)
Cross-listing: Chemistry Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hill SJ, Dao N, Dang VQ, et al. (2023) A Route to Potent, Selective, and Biased Salvinorin Chemical Space. Acs Central Science. 9: 1567-1574
Acevedo-Canabal A, Grim TW, Schmid CL, et al. (2023) Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine. Biomolecules. 13
Shevick SL, Freeman SM, Tong G, et al. (2022) Asymmetric Syntheses of (+)- and (-)-Collybolide Enable Reevaluation of -Opioid Receptor Agonism. Acs Central Science. 8: 948-954
Brust CA, Ho JH, Stahl E, et al. (2022) Functional analysis of key residues involved in CB1 and CB2 activation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology
Stahl E, Schmid CL, Acevedo-Canabal A, et al. (2022) Irreversible and noncompetitive mu opioid receptor agonists. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology
Ma H, Brust T, Frankowski KJ, et al. (2022) Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance. Acs Chemical Neuroscience. 13: 1315-1332
Kolb P, Kenakin T, Alexander SPH, et al. (2022) Community Guidelines for GPCR Ligand Bias: IUPHAR Review XX. British Journal of Pharmacology
Stahl EL, Schmid CL, Acevedo-Canabal A, et al. (2021) G protein signaling-biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists. Proceedings of the National Academy of Sciences of the United States of America. 118
Stahl EL, Bohn LM. (2021) Low Intrinsic Efficacy Alone Cannot Explain the Improved Side Effect Profiles of New Opioid Agonists. Biochemistry
Cornelissen JC, Blough BE, Bohn LM, et al. (2021) Some effects of putative G-protein biased mu-opioid receptor agonists in male rhesus monkeys. Behavioural Pharmacology
See more...